Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Manuel Picon-Ruiz, Cynthia Morata-Tarifa, Janeiro J. Valle-Goffin, Eitan R. Friedman, Joyce M Slingerland

Research output: Contribution to journalReview article

76 Citations (Scopus)

Abstract

Answer questions and earn CME/CNE. Recent decades have seen an unprecedented rise in obesity, and the health impact thereof is increasingly evident. In 2014, worldwide, more than 1.9 billion adults were overweight (body mass index [BMI], 25-29.9 kg/m2), and of these, over 600 million were obese (BMI ≥30 kg/m2). Although the association between obesity and the risk of diabetes and coronary artery disease is widely known, the impact of obesity on cancer incidence, morbidity, and mortality is not fully appreciated. Obesity is associated both with a higher risk of developing breast cancer, particularly in postmenopausal women, and with worse disease outcome for women of all ages. The first part of this review summarizes the relationships between obesity and breast cancer development and outcomes in premenopausal and postmenopausal women and in those with hormone receptor-positive and -negative disease. The second part of this review addresses hypothesized molecular mechanistic insights that may underlie the effects of obesity to increase local and circulating proinflammatory cytokines, promote tumor angiogenesis and stimulate the most malignant cancer stem cell population to drive cancer growth, invasion, and metastasis. Finally, a review of observational studies demonstrates that increased physical activity is associated with lower breast cancer risk and better outcomes. The effects of recent lifestyle interventions to decrease sex steroids, insulin/insulin-like growth factor-1 pathway activation, and inflammatory biomarkers associated with worse breast cancer outcomes in obesity also are discussed. Although many observational studies indicate that exercise with weight loss is associated with improved breast cancer outcome, further prospective studies are needed to determine whether weight reduction will lead to improved patient outcomes. It is hoped that several ongoing lifestyle intervention trials, which are reviewed herein, will support the systematic incorporation of weight loss intervention strategies into care for patients with breast cancer. CA Cancer J Clin 2017;67:378–397.

Original languageEnglish (US)
Pages (from-to)378-397
Number of pages20
JournalCA Cancer Journal for Clinicians
Volume67
Issue number5
DOIs
StatePublished - Sep 1 2017

Fingerprint

Obesity
Breast Neoplasms
Weight Loss
Observational Studies
Life Style
Neoplasms
Body Mass Index
Exercise
Neoplastic Stem Cells
Somatomedins
Coronary Artery Disease
Patient Care
Biomarkers
Steroids
Hormones
Prospective Studies
Insulin
Cytokines
Neoplasm Metastasis
Morbidity

Keywords

  • breast cancer
  • diet and exercise
  • hormone receptor
  • immunity
  • inflammatory cytokines
  • nuclear factor kappa B (NF-κB)
  • obesity
  • postmenopausal and premenopausal
  • sex steroids
  • weight loss

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Obesity and adverse breast cancer risk and outcome : Mechanistic insights and strategies for intervention. / Picon-Ruiz, Manuel; Morata-Tarifa, Cynthia; Valle-Goffin, Janeiro J.; Friedman, Eitan R.; Slingerland, Joyce M.

In: CA Cancer Journal for Clinicians, Vol. 67, No. 5, 01.09.2017, p. 378-397.

Research output: Contribution to journalReview article

Picon-Ruiz, Manuel ; Morata-Tarifa, Cynthia ; Valle-Goffin, Janeiro J. ; Friedman, Eitan R. ; Slingerland, Joyce M. / Obesity and adverse breast cancer risk and outcome : Mechanistic insights and strategies for intervention. In: CA Cancer Journal for Clinicians. 2017 ; Vol. 67, No. 5. pp. 378-397.
@article{2880c8e00ac64e37afeb8f16d7498bc9,
title = "Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention",
abstract = "Answer questions and earn CME/CNE. Recent decades have seen an unprecedented rise in obesity, and the health impact thereof is increasingly evident. In 2014, worldwide, more than 1.9 billion adults were overweight (body mass index [BMI], 25-29.9 kg/m2), and of these, over 600 million were obese (BMI ≥30 kg/m2). Although the association between obesity and the risk of diabetes and coronary artery disease is widely known, the impact of obesity on cancer incidence, morbidity, and mortality is not fully appreciated. Obesity is associated both with a higher risk of developing breast cancer, particularly in postmenopausal women, and with worse disease outcome for women of all ages. The first part of this review summarizes the relationships between obesity and breast cancer development and outcomes in premenopausal and postmenopausal women and in those with hormone receptor-positive and -negative disease. The second part of this review addresses hypothesized molecular mechanistic insights that may underlie the effects of obesity to increase local and circulating proinflammatory cytokines, promote tumor angiogenesis and stimulate the most malignant cancer stem cell population to drive cancer growth, invasion, and metastasis. Finally, a review of observational studies demonstrates that increased physical activity is associated with lower breast cancer risk and better outcomes. The effects of recent lifestyle interventions to decrease sex steroids, insulin/insulin-like growth factor-1 pathway activation, and inflammatory biomarkers associated with worse breast cancer outcomes in obesity also are discussed. Although many observational studies indicate that exercise with weight loss is associated with improved breast cancer outcome, further prospective studies are needed to determine whether weight reduction will lead to improved patient outcomes. It is hoped that several ongoing lifestyle intervention trials, which are reviewed herein, will support the systematic incorporation of weight loss intervention strategies into care for patients with breast cancer. CA Cancer J Clin 2017;67:378–397.",
keywords = "breast cancer, diet and exercise, hormone receptor, immunity, inflammatory cytokines, nuclear factor kappa B (NF-κB), obesity, postmenopausal and premenopausal, sex steroids, weight loss",
author = "Manuel Picon-Ruiz and Cynthia Morata-Tarifa and Valle-Goffin, {Janeiro J.} and Friedman, {Eitan R.} and Slingerland, {Joyce M}",
year = "2017",
month = "9",
day = "1",
doi = "10.3322/caac.21405",
language = "English (US)",
volume = "67",
pages = "378--397",
journal = "Ca-A Cancer Journal for Clinicians",
issn = "0007-9235",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Obesity and adverse breast cancer risk and outcome

T2 - Mechanistic insights and strategies for intervention

AU - Picon-Ruiz, Manuel

AU - Morata-Tarifa, Cynthia

AU - Valle-Goffin, Janeiro J.

AU - Friedman, Eitan R.

AU - Slingerland, Joyce M

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Answer questions and earn CME/CNE. Recent decades have seen an unprecedented rise in obesity, and the health impact thereof is increasingly evident. In 2014, worldwide, more than 1.9 billion adults were overweight (body mass index [BMI], 25-29.9 kg/m2), and of these, over 600 million were obese (BMI ≥30 kg/m2). Although the association between obesity and the risk of diabetes and coronary artery disease is widely known, the impact of obesity on cancer incidence, morbidity, and mortality is not fully appreciated. Obesity is associated both with a higher risk of developing breast cancer, particularly in postmenopausal women, and with worse disease outcome for women of all ages. The first part of this review summarizes the relationships between obesity and breast cancer development and outcomes in premenopausal and postmenopausal women and in those with hormone receptor-positive and -negative disease. The second part of this review addresses hypothesized molecular mechanistic insights that may underlie the effects of obesity to increase local and circulating proinflammatory cytokines, promote tumor angiogenesis and stimulate the most malignant cancer stem cell population to drive cancer growth, invasion, and metastasis. Finally, a review of observational studies demonstrates that increased physical activity is associated with lower breast cancer risk and better outcomes. The effects of recent lifestyle interventions to decrease sex steroids, insulin/insulin-like growth factor-1 pathway activation, and inflammatory biomarkers associated with worse breast cancer outcomes in obesity also are discussed. Although many observational studies indicate that exercise with weight loss is associated with improved breast cancer outcome, further prospective studies are needed to determine whether weight reduction will lead to improved patient outcomes. It is hoped that several ongoing lifestyle intervention trials, which are reviewed herein, will support the systematic incorporation of weight loss intervention strategies into care for patients with breast cancer. CA Cancer J Clin 2017;67:378–397.

AB - Answer questions and earn CME/CNE. Recent decades have seen an unprecedented rise in obesity, and the health impact thereof is increasingly evident. In 2014, worldwide, more than 1.9 billion adults were overweight (body mass index [BMI], 25-29.9 kg/m2), and of these, over 600 million were obese (BMI ≥30 kg/m2). Although the association between obesity and the risk of diabetes and coronary artery disease is widely known, the impact of obesity on cancer incidence, morbidity, and mortality is not fully appreciated. Obesity is associated both with a higher risk of developing breast cancer, particularly in postmenopausal women, and with worse disease outcome for women of all ages. The first part of this review summarizes the relationships between obesity and breast cancer development and outcomes in premenopausal and postmenopausal women and in those with hormone receptor-positive and -negative disease. The second part of this review addresses hypothesized molecular mechanistic insights that may underlie the effects of obesity to increase local and circulating proinflammatory cytokines, promote tumor angiogenesis and stimulate the most malignant cancer stem cell population to drive cancer growth, invasion, and metastasis. Finally, a review of observational studies demonstrates that increased physical activity is associated with lower breast cancer risk and better outcomes. The effects of recent lifestyle interventions to decrease sex steroids, insulin/insulin-like growth factor-1 pathway activation, and inflammatory biomarkers associated with worse breast cancer outcomes in obesity also are discussed. Although many observational studies indicate that exercise with weight loss is associated with improved breast cancer outcome, further prospective studies are needed to determine whether weight reduction will lead to improved patient outcomes. It is hoped that several ongoing lifestyle intervention trials, which are reviewed herein, will support the systematic incorporation of weight loss intervention strategies into care for patients with breast cancer. CA Cancer J Clin 2017;67:378–397.

KW - breast cancer

KW - diet and exercise

KW - hormone receptor

KW - immunity

KW - inflammatory cytokines

KW - nuclear factor kappa B (NF-κB)

KW - obesity

KW - postmenopausal and premenopausal

KW - sex steroids

KW - weight loss

UR - http://www.scopus.com/inward/record.url?scp=85026522079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026522079&partnerID=8YFLogxK

U2 - 10.3322/caac.21405

DO - 10.3322/caac.21405

M3 - Review article

C2 - 28763097

AN - SCOPUS:85026522079

VL - 67

SP - 378

EP - 397

JO - Ca-A Cancer Journal for Clinicians

JF - Ca-A Cancer Journal for Clinicians

SN - 0007-9235

IS - 5

ER -